Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Stress in Pregnant Women can Provoke Allergic Reactions Such as Asthma or Eczema in the Newborn

June 4, 2012

ZURICH, June 4, 2012 /PRNewswire/ –

The latest studies in the field of allergy and clinical immunology will be

presented at the EAACI Congress 2012

[http://www.eaaci2012.com/SiteSpecific/EAACI2012/StartPage.aspx ]

        - Japanese researchers will present findings on how stress affects the fetus
          during pregnancy
        - Health Impacts of Airborne Allergen Information Network will present new
          findings on differences in pollen potency across Europe
        - World's largest Congress on allergy & immunology with delegates from over 100
          countries to present new ways of treating allergies

The European Academy of Allergy and Clinical Immunology (EAACI) will hold its annual
congress 16 – 20 June in Geneva (Switzerland). The latest advances in the field of allergy
and clinical immunology will be presented to specialists from around the world, making it
the leading medical congress on allergy and immunology globally. Ground-breaking research
results will be presented with the goals of reducing the impact of allergy by early
detection, finding ways of prevention and improving the treatment of the growing number of
patients.

Exposure to allergens during pregnancy will be a key topic during the EAACI Congress,
as well as how stress provokes reactions such us as asthma or eczema in the newborn.
Japanese researchers have found that anxiety in pregnant woman is associated with
childhood atopic eczema during the first 8 months of life. The results will be presented
at the Congress.

New findings will also be presented by the Health Impacts of Airborne Allergen
Information Network (HIALINE project), showing the differences in pollen potency between
European countries, and allowing better monitoring of allergies across Europe.

EAACI Congress 2012

The scientific programme
[http://www.eaaci2012.com/SiteSpecific/EAACI2012/SearchProgramme.aspx ] includes an
overview of the current practice trends and provides the best platform to communicate
science and education. From “Childhood, the tipping point towards allergy”, to “Revisiting
the origins of allergy”, the seven plenary symposia are focused on covering the most
current topics in the field.

To complete the scientific agenda, an extensive programme full of sessions, courses,
meetings and workshops will comprehensively address all areas of allergy and clinical
immunology. More than 1,800 abstracts that represent the most recent discoveries in the
field will be discussed in 39 oral presentation sessions and full day accessible poster
sessions.

About EAACI

The European Academy of Allergy and Clinical Immunology, EAACI, is a non-profit
organisation active in the field of allergic and immunologic diseases such as asthma,
rhinitis, eczema, occupational allergy, food and drug allergy and anaphylaxis. EAACI was
founded in 1956 in Florence and has become the largest medical association in Europe in
the field of allergy and clinical immunology. It includes over 6’800 members from 121
countries, as well as 42 National Allergy Societies.

        For more information, please contact:

        Shepard Fox Communications
        Maria Diviney
        maria.diviney@shepard-fox.com
        Tel: +33-95-045-7168
        Mobile: +33-66-620-6462

        Macarena Guillamon
        EAACI Headquarters
        Genferstrasse 21
        8002 Zurich - Switzerland
        Tel: +41-44-205-55-32
        Mobile: +41-79-892-82-25

http://www.eaaci.net

SOURCE European Academy of Allergy and Clinical Immunology (EAACI)


Source: PR Newswire